Given FOXK2’s high expression in a variety of tumors and its close association with tumor proliferation and metastasis, developing FOXK2-specific inhibitors may provide new valuable therapeutic strategies for tumor treatment. The gene discussed is FOXK2; the disease is neoplasm.